The publication of a report showing the Covid vaccine is highly effective at reducing hospitalizations has been delayed by the acting director of the Centers for Disease Control and Prevention.
The Washington Post first reported the delay, citing two scientists familiar with the decision who spoke on the condition of anonymity out of fear of retaliation. A spokesperson for the Department of Health and Human Services confirmed the delay to MS NOW.
Dr. Jay Bhattacharya — an economist who advocated against vaccines during the Covid-19 pandemic and who now helms the National Institutes of Health — took issue with the report’s methodology and held back on publication, the spokesperson said. Bhattacharya was acting director of the CDC at the time and has since been granted broad authority over the agency as the Trump administration searches for a permanent director.
“Dr. Bhattacharya expressed concerns about the observational method used in this study to calculate vaccine effectiveness, and the scientific team is working to address these concerns,” Emily G. Hilliard, the HHS spokesperson, told MS NOW.
The report was slated to publish in a March issue of the CDC’s flagship journal, the Morbidity and Mortality Weekly Report, the scientists told the Post. But Bhattacharya delayed its release despite a study that relied on the same methodology — examining the vaccination status of sick people who sought care at hospitals and emergency rooms — having been published in the CDC journal a week earlier, according to the Post. That study focused on the efficacy of fly vaccines.








